Entry Detail



General Information

Database ID:exR0192503
RNA Name:hsa-miR-130b-3p
RNA Type:miRNA
Chromosome:chr22
Starnd:+
Coordinate:
Start Site(bp):21653354End Site(bp):21653375
External Links:hsa-miR-130b-3p



Disease Information

Disease Name:Epilepsy
Disease Category:Nervous System Diseases
MeSH ID:D004827
Type:Diseases Category/Nervous System Diseases
Alias:Epilepsies//Seizure Disorder//Seizure Disorders//Awakening Epilepsy//Epilepsy, Awakening//Epilepsy, Cryptogenic//Cryptogenic Epilepsies//Cryptogenic Epilepsy//Epilepsies, Cryptogenic//Aura//Auras



Expression Detail

GEO ID:GSE114697
Description:Dual-center, dual-platform microRNA profiling identifies plasma biomarkers of adult temporal lobe epilepsy (Beaumont)
Experimental Design:Disease vs Control
Case Disease Type:Epilepsy
Case Disease SubType:NA
Case Sample:Epilepsy
Control Sample:Control
Number of Case:32
Number of Control:16
Number of Samples:48





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
MLLT1
chr19
6210381
6279975
-
XXYLT1
chr3
195068284
195271159
-
STK38L
chr12
27243968
27325959
+
ZDHHC7
chr16
84974181
85011535
-
OSBP
chr11
59574398
59615774
-
NPAS2
chr2
100820139
100996829
+
G6PD
chrX
154531391
154547572
-
ANKRD52
chr12
56237807
56258384
-
ADAR
chr1
154582057
154628013
-
ZC4H2
chrX
64915802
65034713
-
SNX27
chr1
151612006
151699091
+
USP47
chr11
11841423
11961887
+
ZNF317
chr19
9140397
9163424
+
GADD45A
chr1
67685201
67688334
+
ZBTB7B
chr1
155002630
155018522
+
CALU
chr7
128739292
128773400
+
PCYOX1
chr2
70257386
70281185
+
MPPED2
chr11
30384493
30586872
-
PDRG1
chr20
31944337
31952046
-
CD151
chr11
832887
839831
+
MGRN1
chr16
4616493
4690974
+
TBC1D5
chr3
17157162
18444817
-
ELOC
chr8
73939169
73972287
-
MSTO1
chr1
155610188
155614971
+
IKZF4
chr12
56007659
56038435
+
APOL6
chr22
35648446
35668404
+
TRIM2
chr4
153152342
153339317
+
SYNJ1
chr21
32628759
32728048
-
RHOA
chr3
49359145
49412998
-
TGIF2
chr20
36573488
36593950
+
miRNA targets:NA
circRNA targets:
circRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa_circ_0000591
chr15
41961025
41962156
+
hsa_circ_0001454
chr4
154524454
154533552
+
hsa_circ_0000384
chr12
27867712
27877119
+
hsa_circ_0001723
chr7
91924202
91948826
+
hsa_circ_0000892
chr19
11941431
12014514
+
hsa_circ_0001605
chr6
42903447
42905047
+
hsa_circ_0000155
chr1
168007608
168014465
+
hsa_circ_0001495
chr5
68470703
68471364
+
hsa_circ_0000943
chr19
47421744
47440665
+
hsa_circ_0000018
chr1
15860731
15863309
+
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC011503.2
chr19
23927788
23929287
+
AC021092.1
chr19
44103007
44113183
-
AC135050.6
chr16
31122235
31124064
+
AC234582.1
chr1
155195004
155205495
+
AL031595.3
chr22
44139365
44153626
+
AL049840.4
chr14
103694516
103695050
-
AL158206.1
chr9
19453209
19455173
+
AL158825.2
chr9
75009828
75016036
-
AL603839.3
chr1
40493157
40508661
-
CKMT2-AS1
chr5
81201341
81301565
-
H19
chr11
1995176
2001470
-
HAGLR
chr2
176164051
176188958
-
KCNQ1OT1
chr11
2608328
2699994
-
LINC01089
chr12
121795267
121803906
-
MIR17HG
chr13
91347820
91354579
+
NEAT1
chr11
65422774
65445540
+
XIST
chrX
73820649
73852723
-
Display:



Experiment Detail

GEO ID:GSE114697
Sample Source:Blood
Source Fraction:Plasma
Platform:GPL22992
Method:RT-PCR array
Num of detected RNA Type:1
Num of detected RNAs of this Type:78
Sample treatment protocol:NA
RNA Extract protocol:Total RNA was extracted from 200 ul of plasma using the miRCURY RNA isolation kit-biofluid (Exiqon).
RNA library preparation protocol:3 ul of total RNA was processed by reverse transcriptase and mixed with TaqMan OpenArray Real-Time PCR Master mix (1:1).



Reference

PMID:30396857
Title:Dual-center, dual-platform microRNA profiling identifies potential plasma biomarkers of adult temporal lobe epilepsy
Author:Raoof R, Bauer S, El Naggar H, Connolly NMC, Brennan GP, Brindley E, Hill T, McArdle H, Spain E, Forster RJ, Prehn JHM, Hamer H, Delanty N, Rosenow F, Mooney C, Henshall DC
Journal:EBioMedicine. 2018 Dec;38:127-141.
Description:Using a case-control design, we collected plasma samples from video-electroencephalogram-monitored adult TLE patients at epilepsy specialist centers in two countries, performed genome-wide PCR-based and RNA sequencing during the discovery phase and validated findings in a large (>) cohort of samples that included patients with psychogenic non-epileptic seizures (PNES)